Canada markets open in 9 hours 7 minutes

Abattis Bioceuticals Corp. (ATTBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 01:48PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-09-30
Total Revenue
356.876
356.876
Cost of Revenue
115.54
115.54
Gross Profit
241.336
241.336
Operating Expenses
Research Development
0
0
Selling General and Administrative
4,147
4,147
Total Operating Expenses
4,256
4,256
Operating Income or Loss
-4,015
-4,015
Interest Expense
49.361
49.361
Total Other Income/Expenses Net
1,003
1,003
Income Before Tax
-3,061
-3,061
Income from Continuing Operations
-3,061
-3,061
Net Income
-3,042
-3,042
Net Income available to common shareholders
-3,042
-3,042
Basic EPS
-0.01
-0.01
Diluted EPS
-0.01
-0.01
Basic Average Shares
470,493
470,493
Diluted Average Shares
470,493
470,493